Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sotorasib Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114907259A details a novel one-step hydrolysis and safer urea coupling route for Sotorasib intermediates, offering significant cost and safety advantages.
Patent CN113603636A details a cost-effective Nickel-catalyzed route for 2-isopropyl-3-amino-4-methylpyridine, offering significant supply chain advantages.